10 Infectious Diseases Still Considered Endemic in Specific Regions

9. Human African Trypanosomiasis - Sleeping Sickness in Sub-Saharan Africa

Human African Trypanosomiasis, commonly known as sleeping sickness, is caused by subspecies of Trypanosoma brucei parasites transmitted through the bite of infected tsetse flies. The disease remains endemic in 36 sub-Saharan African countries, with two distinct forms: Trypanosoma brucei gambiense causing chronic infection in West and Central Africa, and Trypanosoma brucei rhodesiense causing acute infection in East Africa. While significant progress has been made in reducing case numbers, with fewer than 1,000 cases reported annually in recent years, the disease continues to pose a threat to rural populations living in tsetse-infested areas. The complex ecology of sleeping sickness involves wild animal reservoirs, domestic livestock, and human populations, making elimination challenging. Environmental factors such as vegetation cover, climate, and land use patterns influence tsetse fly distribution and disease transmission. The disease progresses through two stages: the first stage affects the blood and lymphatic system, while the second stage involves central nervous system invasion, leading to neurological symptoms and eventual death if untreated. Recent advances in treatment, including the oral medication fexinidazole for T. b. gambiense infections, have simplified case management and improved outcomes. However, maintaining surveillance systems, ensuring access to diagnosis and treatment in remote areas, and addressing the animal reservoir remain critical challenges for achieving sustainable elimination of this ancient disease.

10. Buruli Ulcer - The Mysterious Flesh-Eating Disease

Buruli ulcer, caused by Mycobacterium ulcerans, represents one of the most enigmatic endemic diseases, primarily affecting rural populations in West and Central Africa, with additional foci in Australia, Asia, and South America. The disease is characterized by chronic, necrotizing skin lesions that can lead to severe disability and deformity if left untreated. Despite decades of research, the exact mode of transmission remains unclear, though evidence suggests involvement of aquatic environments and possibly aquatic insects as vectors. Endemic areas are typically associated with wetlands, slow-flowing rivers, and areas with recent ecological changes such as dam construction or deforestation. Children and young adults are most commonly affected, with the disease showing a predilection for exposed body parts, particularly the limbs. The production of mycolactone toxin by M. ulcerans causes tissue necrosis and immunosuppression, allowing the infection to progress with minimal inflammatory response. This unique pathogenesis contributes to delayed diagnosis and treatment, as early lesions are often painless and may be mistaken for minor injuries. The social and economic impact of Buruli ulcer is substantial, as advanced cases require extensive treatment, including surgery and prolonged antibiotic therapy. Recent improvements in antibiotic treatment regimens have reduced the need for surgery, but early detection and treatment remain crucial for preventing disability and reducing transmission in endemic communities.